We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Fees calculator to help companies calculate the fees for an initial application for a marketing authorisation.
29 September 2015: early bird rate is available now for the next GCP symposium in Birmingham, which has been added due to popular demand.
MHRA advises the Cell Therapy Catapult on emerging clinical grade induced pluripotent stem cells bank regulation.
The British Pharmacopoeia Commission is seeking to appoint 8 new members (6 professional members and 2 lay members).
UK BioIndustry Association (BIA) and the Medicines and Healthcare products Regulatory Agency (MHRA) report following their fifth joint annual conference.
A new case study is out showing how FUJIFILM Diosynth Biotechnologies (Fujifilm) engaged MHRA early to future-proof mammalian cell culture manufacturing facility.
How we helped FUJIFILM Diosynth Biotechnologies (Fujifilm) future proof mammalian cell culture manufacturing facility.
MHRA has today published its first blog.
From 1 July 2015, MHRA will fully adopt use of the common repository for centralised procedures.
Register now for the fifth joint BioIndustry Association (BIA) and MHRA conference.
The suspension of Kool Pharma Ltd's licence has been lifted.
From 1 April 2015, MHRA will be issuing Certificates of Free Sale for medical devices.
How MHRA and OxSonics help cancer drugs go the extra mile.
MHRA supports innovation in anti-cancer drug delivery by providing regulatory advice to OxSonics early on in the process.
People with diabetes who use insulin pens manufactured by Owen Mumford are today being warned by the Medicines and Healthcare products Regulatory Agency (MHRA) to check if they have an affected lot.
Early collaboration with MHRA helps AstraZeneca to continue to supply critical cancer medicine.
The Advisory Council on the Misuse of Drugs has recommended the control of three prescription medicines
ACMD advice on Sativex, February 2013.
Letter from Professor David Salisbury concerning the recall of a batch of the influenza vaccine, Preflucel.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
This letter from Professor Les Iversen recommends curbing the import of the drug phenazepam.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).